Daniel Kazado is Director at IMMUNE PHARMACEUTICALS INC (IMNP). They have made 6 open-market trades across 1 company since 2014, most recently 2017-01-04.
CIK 0001589342
6 open-market purchases totalling $856K since 2014, never a sale. Across 6 scored buys the stock is down 15.3% at ninety days, and 16.3 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| IMNP | 1,145,171 | $189K |
Shares reported on the most recent Form 4, priced at the 2017-01-04 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 0% | 0% |
| Avg Move | +2.0% | -15.3% | -15.3% |
| Alpha | -10.9% | -15.2% | -16.3% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMNP | BUY | 2017-01-04 | 2017-01-04 | $0.19 | $15K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2016-12-16 | 2016-12-20 | $0.19 | $31K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2016-08-04 | 2016-08-04 | $0.45 | $600K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2015-12-07 | 2015-12-08 | $0.78 | $117K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2015-09-14 | 2015-09-16 | $1.47 | $74K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2014-11-26 | 2014-12-03 | $2.50 | $20K | +2.0% | -15.3% | -15.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.